2024 #ESCGuidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic diseases of @escardio, Endorsed by the European Association for Cardio-Thoracic Surgery @EACTS, the European Reference Network on Rare Multisystemic Vascular Diseases @vascern, and the European Society of Vascular Medicine @ESVM_
Central illustration 👇
#ESCCongress
2024 #ESCGuidelines for the management of #afib developed in collaboration with the European Association for Cardio-Thoracic Surgery @EACTS : Developed by the task force for the management of atrial fibrillation of @escardio, with the special contribution of the European Heart Rhythm Association #EHRA_ESC. Endorsed by the European Stroke Organisation @ESOstroke
Central illustration 👇
#ESCCongress
New #ESCGuidelines are out @mirvatalasnag brings you the highlights from the new guidelines on peripheral arterial and aortic diseases.
Full document: https://t.co/ic1XYojR9Y
Listen to @DrJasonAndrade sharing the main take home messages from the new guidelines on #AtrialFibrillation Full document: https://t.co/ytMwiPNw1V
#ESCCongress
🔴 ASE Recommendations for Evaluation of Prosthetic Valves with Echo & Doppler Ultrasound
🔹Normal Flow Patterns & Essential Parameters in the Evaluation of Prosthetic Valves
🔹 Prosthetic Aortic, Mitral,Tricuspid & Pulmonic Valves
#DidYouKnow we have an entire Microlesson Series on HCM, comprised of 15 videos that dive into all things #HCM? 🫀
View them all on our YouTube channel: https://t.co/ao4TNZv2CN
#echofirst knows how 2️⃣♠️different types of ASD in just 3️⃣TEE views. Spatial orientation is essential for better understanding of echo images, ‘cause the 👀see what the 🧠 knows #CardioTwitter, #CHD, #PedsCard part 2️⃣⤵️
New clinical consensus statement from ESC's HFA/EAPCI on Chronic Right-Sided Heart Failure and Tricuspid Regurgitation. Epub ahead of print. https://t.co/8FhTxPJbQs @escardio@ESC_Journals @MariannaAdamo1 @lpbadano@VDelgadoGarcia@FabienPraz@MarcoMetra see also https://t.co/Uu1mF71CdI
#Clopidogrel monotherapy following 1-month #DAPT is associated with numerically lower rate of composite CV outcomes and significantly ⬇️ CV events compared with #aspirin monotherapy following 12-month DAPT. https://t.co/cdbxy1PT4Z
#JACC#PCI#STOPDAPT2@HirotWatanabeMD